Skip to main content

Axsome Therapeutics, Inc.

AXSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001579428

In the last 90 days, Axsome Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 505 institutions reported holding it in 13F filings for Q2 2026, worth $9.34B in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Axsome Therapeutics, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of AXSM: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders197231+34
Shares31.9M36.4M+4.49M (+14.1%)
Value$1.97B$2.61B+$647.0M (+32.9%)

New holders (50)

Institutions that held Axsome Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to AXSM in Q2 2023
InstitutionSharesValue% of portfolio
Ra Capital Management, L.P.1,000,000$71.9M1.36%
Deep Track Capital, LP384,200$27.6M1.29%
Farallon Capital Management, L.L.C.272,800$19.6M0.12%
Perceptive Advisors LLC271,493$19.5M0.57%
Wellington Management Group LLP199,711$14.4M0.00%
Clear Street LLC131,500$9.45M0.23%
Alyeska Investment Group, L.P.125,000$8.98M0.07%
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)100,000$7.19M0.15%
Artia Global Partners LP87,848$6.31M2.18%
Walleye Capital LLC86,280$6.20M0.11%
Monashee Investment Management LLC75,000$5.39M1.29%
National Bank of Canada69,423$4.99M0.01%
International Biotechnology Trust PLC58,300$4.19M1.27%
Altium Capital Management LP40,000$2.87M2.25%
Maven Securities LTD35,000$2.52M0.36%
Lisanti Capital Growth, LLC33,325$2.39M0.33%
Sassicaia Capital Advisers LLC24,000$1.72M1.48%
EAM Investors, LLC18,102$1.30M0.24%
Fred Alger Management, LLC17,422$1.25M0.01%
Harvest Investment Services, LLC16,349$1.17M0.67%
Polar Asset Management Partners Inc.15,465$1.11M0.02%
Quantitative Investment Management, LLC15,300$1.10M0.10%
Moore Capital Management, LP15,000$1.08M0.03%
Oak Ridge Investments LLC13,027$936.1K0.12%
Calamos Advisors LLC12,755$916.6K0.00%
Affinity Asset Advisors, LLC12,500$898.3K0.35%
Kennedy Capital Management, Inc.9,738$699.8K0.02%
Advisory Research Inc8,671$623.1K0.08%
Wolverine Trading, LLC7,819$571.7K0.01%
Capula Management Ltd7,720$554.8K0.07%
GTS Securities LLC6,673$479.5K0.02%
Commonwealth Equity Services, LLC5,183$372.0K0.00%
Walleye Trading LLC5,168$371.4K0.02%
Janney Montgomery Scott LLC4,487$322.0K0.00%
American Century Companies Inc3,893$279.8K0.00%
NinePointTwo Capital3,599$258.0K0.10%
National Asset Management, Inc.3,347$240.5K0.01%
Brinker Capital Investments, LLC3,344$240.3K0.00%
Orion Portfolio Solutions, LLC3,344$240.3K0.00%
Kaizen Financial Strategies3,200$237.5K0.20%
Shay Capital LLC3,200$230.0K0.08%
Intrust Bank NA3,046$218.9K0.03%
XTX Topco Ltd2,868$206.1K0.04%
Captrust Financial Advisors2,851$204.9K0.00%
HighTower Advisors, LLC2,778$199.0K0.00%
Ci Investments Inc.824$59.0K0.00%
Headlands Technologies LLC325$23.4K0.01%
Barclays PLC73$5.25K0.00%
Impact Partnership Wealth, LLC15$1.08K0.00%
Bell Investment Advisors, Inc13$9350.00%

Sold out (16)

Institutions that held Axsome Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.